2024-12-18 Gammon Construction HaiPress
The Land Transport Authority (LTA) has awarded Gammon contract CR173A – Supply and Installation of Mechanical Services for Changi East Depot
SINGAPORE,Dec. 18,2024 -- Gammon has been awarded contract CR173A – Supply and Installation of Mechanical Services for Changi East Depot at a contract value of S$136.6 million by the Land Transport Authority (LTA).
This contract,valued at S$136.6 million encompasses the supply,installation,testing and commissioning of key mechanical systems,including Environmental Control Systems (ECS),Building Management System (BMS) and Fire Protection Systems (FPS). The project is scheduled to complete in 2030.
The Changi East Depot located in the Changi East Industrial Zone,will serve as the main facility for the Cross Island Line (CRL). This project marks another milestone in Gammon's longstanding partnership with LTA.
"At Gammon,safety is at the core of our values. It is integral in ensuring effective and efficient construction in our projects." said Colin Tan,Director of Gammon. He also reaffirmed the company's dedication to the Zero Accident Safety Pledge,emphasising the highest safety standards throughout the operation.
Speaking at the Letter of Award (LOA) signing ceremony on 22 November 2024,LTA expressed confidence in Gammon's ability to add value to the CR173A project. "We are confident that Gammon will continue to add value to the CR173A project while maintaining a strong focus on safe project execution." LTA also commended Gammon's proactive use of technology and Design for Manufacturing and Assembly (DFMA) methods in recent projects,which have enhanced productivity and safety. LTA encouraged Gammon to continue adopting innovative technologies to further improve on-site safety and productivity. The LOA signing ceremony was attended by senior members of LTA and project team of Gammon.
An artist’s impression of the CR173A project.
Jewellery & Gem ASEAN Bangkok (JGAB) 2025: Connecting ASEAN's Gem and Jewellery Business to the Global Market
BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors
Acer Reports FY2024 Net Income of NT$5.54 Billion and NT$1.7 Cash Dividend Per Share
Ping An #1 in Brand Finance's Global Insurance Brand Value for 9th Year, Brand Value Reaches $33.6 Billion
LITEON Showcase Groundbreaking Energy Savings in Private 5G Network with NTT EAST at MWC 2025
2025 Global Sources Hong Kong Shows: Shaping the Future of Consumer Trends and Redefining Sourcing
©copyright 2009-2020 Diet Tips Daily